{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:52:33Z","timestamp":1781657553587,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48752-4","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:05:31Z","timestamp":1777003531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic determinants and predictive modeling in higher-grade glioma patients receiving radiotherapy: a retrospective SEER-based study"],"prefix":"10.1038","volume":"16","author":[{"given":"Ruijinlin","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanxuan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"48752_CR1","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","volume":"23","author":"QT Ostrom","year":"2021","unstructured":"Ostrom, Q. T., Cioffi, G., Waite, K., Kruchko, C. & Barnholtz-Sloan, J. S. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018. Neuro-oncology 23, iii1\u2013iii105. https:\/\/doi.org\/10.1093\/neuonc\/noab200 (2021).","journal-title":"Neuro-oncology"},{"key":"48752_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro-oncology 23, 1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106 (2021).","journal-title":"Neuro-oncology"},{"key":"48752_CR3","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/jamaoncol.2022.2844","volume":"8","author":"TR Berger","year":"2022","unstructured":"Berger, T. R., Wen, P. Y., Lang-Orsini, M. & Chukwueke, U. N. World Health Organization 2021 classification of central nervous system tumors and implications for therapy for adult-type gliomas: A review. JAMA Oncol. 8, 1493\u20131501. https:\/\/doi.org\/10.1001\/jamaoncol.2022.2844 (2022).","journal-title":"JAMA Oncol."},{"key":"48752_CR4","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.ijrobp.2024.11.094","volume":"121","author":"Y Qiu","year":"2025","unstructured":"Qiu, Y. et al. Toxicity and efficacy of different target volume delineations of radiation therapy based on the updated radiation therapy oncology group\/national research group and european organization for research and treatment of cancer guidelines in patients with grade 3\u20134 glioma: A randomized controlled clinical trial. Int. J. Radiat. Oncol. Biol. Phys. 121, 1168\u20131181. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.11.094 (2025).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"48752_CR5","doi-asserted-by":"publisher","first-page":"e1838","DOI":"10.1002\/wnan.1838","volume":"15","author":"D Liu","year":"2023","unstructured":"Liu, D. et al. Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 15, e1838. https:\/\/doi.org\/10.1002\/wnan.1838 (2023).","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"48752_CR6","doi-asserted-by":"publisher","first-page":"1347877","DOI":"10.3389\/fimmu.2024.1347877","volume":"15","author":"A Ballest\u00edn","year":"2024","unstructured":"Ballest\u00edn, A., Armocida, D., Ribecco, V. & Seano, G. Peritumoral brain zone in glioblastoma: Biological, clinical and mechanical features. Front. Immunol. 15, 1347877. https:\/\/doi.org\/10.3389\/fimmu.2024.1347877 (2024).","journal-title":"Front. Immunol."},{"key":"48752_CR7","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/brain\/awac450","volume":"146","author":"D Qi","year":"2023","unstructured":"Qi, D., Li, J., Quarles, C. C., Fonkem, E. & Wu, E. Assessment and prediction of glioblastoma therapy response: Challenges and opportunities. Brain: J. Neurol. 146, 1281\u20131298. https:\/\/doi.org\/10.1093\/brain\/awac450 (2023).","journal-title":"Brain: J. Neurol."},{"key":"48752_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/neuonc\/noad158","volume":"26","author":"H Pinson","year":"2024","unstructured":"Pinson, H. et al. Epidemiology and survival of adult-type diffuse glioma in Belgium during the molecular era. Neuro-oncology 26, 191\u2013202. https:\/\/doi.org\/10.1093\/neuonc\/noad158 (2024).","journal-title":"Neuro-oncology"},{"key":"48752_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan, A. C. et al. Management of glioblastoma: State of the art and future directions. Cancer J. Clin. 70, 299\u2013312. https:\/\/doi.org\/10.3322\/caac.21613 (2020).","journal-title":"Cancer J. Clin."},{"key":"48752_CR10","doi-asserted-by":"publisher","first-page":"n1560","DOI":"10.1136\/bmj.n1560","volume":"374","author":"C McKinnon","year":"2021","unstructured":"McKinnon, C., Nandhabalan, M., Murray, S. A. & Plaha, P. Glioblastoma: Clinical presentation, diagnosis, and management. BMJ (Clin. Res. ed.). 374, n1560. https:\/\/doi.org\/10.1136\/bmj.n1560 (2021).","journal-title":"BMJ (Clin. Res. ed.)"},{"key":"48752_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1200\/jco.2016.70.7562","volume":"35","author":"EP Sulman","year":"2017","unstructured":"Sulman, E. P. et al. Radiation therapy for glioblastoma: American society of clinical oncology clinical practice guideline endorsement of the American society for radiation oncology guideline. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 35, 361\u2013369. https:\/\/doi.org\/10.1200\/jco.2016.70.7562 (2017).","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"48752_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ijrobp.2009.08.029","volume":"78","author":"KH Cho","year":"2010","unstructured":"Cho, K. H. et al. Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade gliomas. Int. J. Radiat. Oncol. Biol. Phys. 78, 390\u2013397. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.08.029 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"48752_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3340\/jkns.2008.44.4.222","volume":"44","author":"JW Choi","year":"2008","unstructured":"Choi, J. W. et al. The outcomes of concomitant chemoradiotherapy followed by adjuvant chemotherapy with temozolomide for newly diagnosed high grade gliomas: the preliminary results of single center prospective study. J. Korean Neurosurg. Soc. 44, 222\u2013227. https:\/\/doi.org\/10.3340\/jkns.2008.44.4.222 (2008).","journal-title":"J. Korean Neurosurg. Soc."},{"key":"48752_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/neuonc\/now208","volume":"19","author":"H Gittleman","year":"2017","unstructured":"Gittleman, H. et al. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG oncology RTOG 0525 and 0825. Neuro-oncology 19, 669\u2013677. https:\/\/doi.org\/10.1093\/neuonc\/now208 (2017).","journal-title":"Neuro-oncology"},{"key":"48752_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1600-0404.2010.01350.x","volume":"122","author":"R Helseth","year":"2010","unstructured":"Helseth, R. et al. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol. Scand. 122, 159\u2013167. https:\/\/doi.org\/10.1111\/j.1600-0404.2010.01350.x (2010).","journal-title":"Acta Neurol. Scand."},{"key":"48752_CR16","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3389\/fonc.2020.01051","volume":"10","author":"H Li","year":"2020","unstructured":"Li, H., He, Y., Huang, L., Luo, H. & Zhu, X. The nomogram model predicting overall survival and guiding clinical decision in patients with glioblastoma based on the SEER database. Front. Oncol. 10, 1051. https:\/\/doi.org\/10.3389\/fonc.2020.01051 (2020).","journal-title":"Front. Oncol."},{"key":"48752_CR17","doi-asserted-by":"publisher","first-page":"117966","DOI":"10.1016\/j.ecoenv.2025.117966","volume":"292","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Air pollution and prostate cancer: Unraveling the connection through network toxicology and machine learning. Ecotoxicol. Environ. Saf. 292, 117966. https:\/\/doi.org\/10.1016\/j.ecoenv.2025.117966 (2025).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"48752_CR18","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1111\/cas.14927","volume":"112","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancer. Cancer Sci. 112, 2905\u20132914. https:\/\/doi.org\/10.1111\/cas.14927 (2021).","journal-title":"Cancer Sci."},{"key":"48752_CR19","doi-asserted-by":"publisher","first-page":"18301","DOI":"10.1038\/s41598-023-45438-z","volume":"13","author":"X Zhong","year":"2023","unstructured":"Zhong, X., Lin, Y., Zhang, W. & Bi, Q. Predicting diagnosis and survival of bone metastasis in breast cancer using machine learning. Sci. Rep. 13, 18301. https:\/\/doi.org\/10.1038\/s41598-023-45438-z (2023).","journal-title":"Sci. Rep."},{"key":"48752_CR20","doi-asserted-by":"publisher","first-page":"e756","DOI":"10.1093\/neuros\/nyz145","volume":"85","author":"CHB van Niftrik","year":"2019","unstructured":"van Niftrik, C. H. B. et al. Machine learning algorithm identifies patients at high risk for early complications after intracranial tumor surgery: Registry-based cohort study. Neurosurgery 85, e756\u2013e764. https:\/\/doi.org\/10.1093\/neuros\/nyz145 (2019).","journal-title":"Neurosurgery"},{"key":"48752_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/1471-2407-11-325","volume":"11","author":"R Dubrow","year":"2011","unstructured":"Dubrow, R. & Darefsky, A. S. Demographic variation in incidence of adult glioma by subtype, United States, 1992\u20132007. BMC cancer. 11, 325. https:\/\/doi.org\/10.1186\/1471-2407-11-325 (2011).","journal-title":"BMC cancer"},{"key":"48752_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.neucir.2017.07.005","volume":"28","author":"D Alonso","year":"2017","unstructured":"Alonso, D., Matallanas, M., Riveros-P\u00e9rez, A., P\u00e9rez-Payo, M. & Blanco, S. Prognostic and predictive factors in high-grade gliomas. Experience at our institution. Neurocirugia (Asturias Spain). 28, 276\u2013283. https:\/\/doi.org\/10.1016\/j.neucir.2017.07.005 (2017).","journal-title":"Neurocirugia (Asturias Spain)"},{"key":"48752_CR23","doi-asserted-by":"publisher","first-page":"1346340","DOI":"10.1155\/2020\/1346340","volume":"2020","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. Prognostic nomograms for primary high-grade glioma patients in adult: A retrospective study based on the SEER database. Biomed. Res. Int. 2020, 1346340. https:\/\/doi.org\/10.1155\/2020\/1346340 (2020).","journal-title":"Biomed. Res. Int."},{"key":"48752_CR24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2217\/ahe.11.56","volume":"7","author":"AD Foster","year":"2011","unstructured":"Foster, A. D., Sivarapatna, A. & Gress, R. E. The aging immune system and its relationship with cancer. Aging health. 7, 707\u2013718. https:\/\/doi.org\/10.2217\/ahe.11.56 (2011).","journal-title":"Aging health"},{"key":"48752_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.critrevonc.2009.06.002","volume":"74","author":"L Malaguarnera","year":"2010","unstructured":"Malaguarnera, L., Cristaldi, E. & Malaguarnera, M. The role of immunity in elderly cancer. Crit. Rev. Oncol. Hematol. 74, 40\u201360. https:\/\/doi.org\/10.1016\/j.critrevonc.2009.06.002 (2010).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"48752_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2176\/nmc.ra.2017-0009","volume":"57","author":"M Okada","year":"2017","unstructured":"Okada, M., Miyake, K. & Tamiya, T. Glioblastoma treatment in the elderly. Neurol. Med. Chir. 57, 667\u2013676. https:\/\/doi.org\/10.2176\/nmc.ra.2017-0009 (2017).","journal-title":"Neurol. Med. Chir."},{"key":"48752_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semradonc.2009.08.001","volume":"20","author":"P Rubin","year":"2010","unstructured":"Rubin, P., Williams, J. P., Devesa, S. S., Travis, L. B. & Constine, L. S. Cancer genesis across the age spectrum: Associations with tissue development, maintenance, and senescence. Semin. Radiat. Oncol. 20, 3\u201311. https:\/\/doi.org\/10.1016\/j.semradonc.2009.08.001 (2010).","journal-title":"Semin. Radiat. Oncol."},{"key":"48752_CR28","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.clon.2017.05.010","volume":"29","author":"CF Lorimer","year":"2017","unstructured":"Lorimer, C. F., Hanna, C., Saran, F., Chalmers, A. & Brock, J. Challenges to treating older glioblastoma patients: The influence of clinical and tumour characteristics on survival outcomes. Clin. Oncol. (R. Coll. Radiol. (G. B.)). 29, 739\u2013747. https:\/\/doi.org\/10.1016\/j.clon.2017.05.010 (2017).","journal-title":"Clin. Oncol. (R. Coll. Radiol. (G. B.))"},{"key":"48752_CR29","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330 (2005).","journal-title":"N. Engl. J. Med."},{"key":"48752_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/14712598.2022.2157718","volume":"23","author":"ML Varela","year":"2023","unstructured":"Varela, M. L. et al. Gene therapy for high grade glioma: The clinical experience. Expert Opin. Biol. Ther. 23, 145\u2013161. https:\/\/doi.org\/10.1080\/14712598.2022.2157718 (2023).","journal-title":"Expert Opin. Biol. Ther."},{"key":"48752_CR31","doi-asserted-by":"publisher","first-page":"e8444","DOI":"10.1097\/md.0000000000008444","volume":"96","author":"Z Wang","year":"2017","unstructured":"Wang, Z., Yang, G., Zhang, Y. Y., Yao, Y. & Dong, L. H. A comparison between oral chemotherapy combined with radiotherapy and radiotherapy for newly diagnosed glioblastoma: A systematic review and meta-analysis. Medicine 96, e8444. https:\/\/doi.org\/10.1097\/md.0000000000008444 (2017).","journal-title":"Medicine"},{"key":"48752_CR32","first-page":"2585","volume":"6","author":"HS Friedman","year":"2000","unstructured":"Friedman, H. S., Kerby, T. & Calvert, H. Temozolomide and treatment of malignant glioma. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 6, 2585\u20132597 (2000).","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"48752_CR33","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1054\/bjoc.2000.1316","volume":"83","author":"WK Yung","year":"2000","unstructured":"Yung, W. K. et al. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br. J. Cancer. 83, 588\u2013593. https:\/\/doi.org\/10.1054\/bjoc.2000.1316 (2000).","journal-title":"Br. J. Cancer"},{"key":"48752_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/s1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp, R. et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10, 459\u2013466. https:\/\/doi.org\/10.1016\/s1470-2045(09)70025-7 (2009).","journal-title":"Lancet Oncol."},{"key":"48752_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3390\/biomedicines9030324","volume":"9","author":"JP Fisher","year":"2021","unstructured":"Fisher, J. P. & Adamson, D. C. Current FDA-approved therapies for high-grade malignant gliomas. Biomedicines 9, 324. https:\/\/doi.org\/10.3390\/biomedicines9030324 (2021).","journal-title":"Biomedicines"},{"key":"48752_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3171\/jns.1978.49.3.0333","volume":"49","author":"MD Walker","year":"1978","unstructured":"Walker, M. D. et al. Evaluation of BCNU and\/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J. Neurosurg. 49, 333\u2013343. https:\/\/doi.org\/10.3171\/jns.1978.49.3.0333 (1978).","journal-title":"J. Neurosurg."},{"key":"48752_CR37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1200\/jco.2012.43.2674","volume":"31","author":"G Cairncross","year":"2013","unstructured":"Cairncross, G. et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: Long-term results of RTOG 9402. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 31, 337\u2013343. https:\/\/doi.org\/10.1200\/jco.2012.43.2674 (2013).","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"48752_CR38","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1200\/jco.2012.43.2229","volume":"31","author":"MJ van den Bent","year":"2013","unstructured":"van den Bent, M. J. et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: Long-term follow-up of EORTC brain tumor group study 26951. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 31, 344\u2013350. https:\/\/doi.org\/10.1200\/jco.2012.43.2229 (2013).","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"48752_CR39","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.2174\/156800912803251207","volume":"12","author":"GP Spinelli","year":"2012","unstructured":"Spinelli, G. P. et al. Chemotherapy and target therapy in the management of adult high- grade gliomas. Curr. Cancer Drug Targets 12, 1016\u20131031. https:\/\/doi.org\/10.2174\/156800912803251207 (2012).","journal-title":"Curr. Cancer Drug Targets"},{"key":"48752_CR40","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1200\/jco.2011.40.8617","volume":"30","author":"CH Pui","year":"2012","unstructured":"Pui, C. H. et al. Treatment outcomes in black and white children with cancer: Results from the SEER database and St Jude Children\u2019s Research Hospital, 1992 through 2007. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 30, 2005\u20132012. https:\/\/doi.org\/10.1200\/jco.2011.40.8617 (2012).","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"48752_CR41","doi-asserted-by":"publisher","first-page":"1401977","DOI":"10.3389\/fonc.2024.1401977","volume":"14","author":"R Tan","year":"2024","unstructured":"Tan, R., Sui, C., Wang, C. & Zhu, T. MRI-based intratumoral and peritumoral radiomics for preoperative prediction of glioma grade: A multicenter study. Front. Oncol. 14, 1401977. https:\/\/doi.org\/10.3389\/fonc.2024.1401977 (2024).","journal-title":"Front. Oncol."},{"key":"48752_CR42","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1002\/cam4.3838","volume":"10","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. A machine learning-based survival prediction model of high grade glioma by integration of clinical and dose-volume histogram parameters. Cancer Med. 10, 2774\u20132786. https:\/\/doi.org\/10.1002\/cam4.3838 (2021).","journal-title":"Cancer Med."},{"key":"48752_CR43","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3390\/diagnostics11091714","volume":"11","author":"DD Rufo","year":"2021","unstructured":"Rufo, D. D., Debelee, T. G., Ibenthal, A. & Negera, W. G. Diagnosis of diabetes mellitus using gradient boosting machine (LightGBM). Diagnostics (Basel Switzerland). 11, 1714. https:\/\/doi.org\/10.3390\/diagnostics11091714 (2021).","journal-title":"Diagnostics (Basel Switzerland)"},{"key":"48752_CR44","doi-asserted-by":"publisher","first-page":"1324933","DOI":"10.3389\/fnins.2024.1324933","volume":"18","author":"X Xiong","year":"2024","unstructured":"Xiong, X. et al. Application of LightGBM hybrid model based on TPE algorithm optimization in sleep apnea detection. Front. NeuroSci. 18, 1324933. https:\/\/doi.org\/10.3389\/fnins.2024.1324933 (2024).","journal-title":"Front. NeuroSci."},{"key":"48752_CR45","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11060-025-05099-6","volume":"175","author":"Y Mao","year":"2025","unstructured":"Mao, Y. et al. Automated feature learning and survival prognostication in grade 4 glioma using supervised machine learning models. J. Neurooncol. 175, 389\u2013403. https:\/\/doi.org\/10.1007\/s11060-025-05099-6 (2025).","journal-title":"J. Neurooncol."},{"key":"48752_CR46","doi-asserted-by":"publisher","first-page":"31114","DOI":"10.1038\/s41598-025-15553-0","volume":"15","author":"D Li","year":"2025","unstructured":"Li, D. et al. Development and validation of a machine learning-based survival prediction model for Asian glioblastoma patients using the SEER database and Chinese data. Sci. Rep. 15, 31114. https:\/\/doi.org\/10.1038\/s41598-025-15553-0 (2025).","journal-title":"Sci. Rep."},{"key":"48752_CR47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.62411\/faith.2024-16","volume":"1","author":"T Noviandy","year":"2024","unstructured":"Noviandy, T., Idroes, G. & Hardi, I. An interpretable machine learning strategy for antimalarial drug discovery with LightGBM and SHAP. J. Future Artif. Intell. Technol. 1, 84\u201395. https:\/\/doi.org\/10.62411\/faith.2024-16 (2024).","journal-title":"J. Future Artif. Intell. Technol."},{"key":"48752_CR48","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3390\/sym16050532","volume":"16","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Product quality anomaly recognition and diagnosis based on DRSN-SVM-SHAP. Symmetry 16, 532. https:\/\/doi.org\/10.3390\/sym16050532 (2024).","journal-title":"Symmetry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48752-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48752-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48752-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:01:00Z","timestamp":1781654460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48752-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48752"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48752-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18818"}}